Atrial Fibrillation Associated With Heart Failure Treated by BIOTRONIK's CRT-DX System

TerminatedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

May 28, 2021

Primary Completion Date

December 29, 2021

Study Completion Date

December 29, 2021

Conditions
Heart FailureAtrial FibrillationCardiac Resynchronization Therapy
Interventions
DEVICE

CRT-DX

Evaluation of overall health, including heart failure and atrial fibrillation improvement, changes in physical fitness, and general quality of life.

Trial Locations (23)

10021

Weill Cornell Medicine, New York

10075

Lenox Hill Hospital, New York

27834

Heart Rhythm Associates, Greenville

29425

Medical University of South Carolina, Charleston

29607

Upstate Cardiology, Greenville

33613

AdventHealth Tampa, Tampa

37403

Erlanger Institute for Clinical Research, Chattanooga

38801

Cardiology Associates of North Mississippi, Tupelo

38806

Orlando Health Heart Institute, Orlando

40503

Baptist Health Lexington, Lexington

40536

University of Kentucky - Gill Heart and Vascular Institute, Lexington

43615

ProMedica Northwest Ohio Cardiology Consultants, Toledo

45267

University of Cincinnati, Cincinnati

48109

University of Michigan, Ann Arbor

48197

Michigan Heart, Ypsilanti

52242

University of Iowa Hospitals and Clinics, Iowa City

59901

Glacier View Research Institute Cardiology, Kalispell

65804

Mercy Hospital Springfield, Springfield

66160

University of Kansas Medical Center, Kansas City

66211

Kansas City Heart Rhythm Institute, Overland Park

92037

University of California San Diego - La Jolla, La Jolla

93003

Cardiology Associates Medical Group, Ventura

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biotronik, Inc.

INDUSTRY